Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China · Delayed Price · Currency is CNY 55.33
+0.50 (0.91%)
Oct 27, 2025, 11:30 AM CST
Sunshine Guojian Pharmaceutical (Shanghai) Company Description
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
Its products include YISAIPU, a tumor necrosis factor inhibitor type II-antibody fusion protein for the treatment of autoimmune rheumatism and immunology; Septin, an injection for anti-human epidermal growth factor receptor-2 treatment; and Jiannipa, a recombinant anti-CD25 humanized monoclonal antibody injection to prevent acute rejection caused by kidney transplantation.
The company was founded in 2002 and is based in Shanghai, China.
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
| Country | China |
| Founded | 2002 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 995 |
| CEO | Yanli Liu |
Contact Details
Address: No. 399, Libing Road Shanghai, 201203 China | |
| Phone | 86 21 8029 7777 |
| Website | 3s-guojian.com |
Stock Details
| Ticker Symbol | 688336 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000062X2 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Yanli Liu | GM and Director |
| Qi Zhang | Secretary of Board of Directors |
| Hongmei Niu | Chief Financial Officer |
| Lirong Zheng | Accounting Supervisor |